Bone Diseases, Metabolic Completed Phase 4 Trials for Pamidronic acid (DB00282)

Also known as: Bone Disease, Metabolic

IndicationStatusPhase
DBCOND0028429 (Bone Diseases, Metabolic)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00657852Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver TransplantTreatment